Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | PF-07329640 |
| Trade Name | |
| Synonyms | PF07329640|PF 07329640 |
| Drug Descriptions |
Limited information is currently available on PF-07329640, a putative LTBR agonist antibody (Jun 2024). |
| DrugClasses | |
| CAS Registry Number | NA |
| NCIT ID | NA |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Bevacizumab + PF-07329640 | Bevacizumab PF-07329640 | 0 | 1 |
| PF-06801591 + PF-07329640 | PF-06801591 PF-07329640 | 0 | 1 |
| PF-07329640 | PF-07329640 | 0 | 1 |